Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study

Clinical Pharmacology and Therapeutics
P WeekeC Torp-Pedersen

Abstract

Treatment with some types of antidepressants has been associated with sudden cardiac death. It is unknown whether the increased risk is due to a class effect or related to specific antidepressants within drug classes. All patients in Denmark with an out-of-hospital cardiac arrest (OHCA) were identified (2001-2007). Association between treatment with specific antidepressants and OHCA was examined by conditional logistic regression in case-time-control models. We identified 19,110 patients with an OHCA; 2,913 (15.2%) were receiving antidepressant treatment at the time of OHCA, with citalopram being the most frequently used type of antidepressant (50.8%). Tricyclic antidepressants (TCAs; odds ratio (OR) = 1.69, confidence interval (CI): 1.14-2.50) and selective serotonin reuptake inhibitors (SSRIs; OR = 1.21, CI: 1.00-1.47) were both associated with comparable increases in risk of OHCA, whereas no association was found for serotonin-norepinephrine reuptake inhibitors/noradrenergic and specific serotonergic antidepressants (SNRIs/NaSSAs; OR = 1.06, CI: 0.81-1.39). The increased risks were primarily driven by: citalopram (OR = 1.29, CI: 1.02-1.63) and nortriptyline (OR = 5.14, CI: 2.17-12.2). An association between cardiac arrest an...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Jan 1, 1992·Journal of Neural Transmission. General Section·J HyttelC Sánchez
May 1, 1995·Epidemiology·S Suissa
Jul 17, 1998·Archives of Internal Medicine·D E FordM J Klag
Aug 3, 2001·European Heart Journal·S G PrioriD P Zipes
Oct 24, 2001·Circulation·R M CarneyK E Freedland
Aug 10, 2002·JAMA : the Journal of the American Medical Association·Alexander H GlassmanUNKNOWN Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Lisa F BerkmanUNKNOWN Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD)
Mar 6, 2004·Clinical Pharmacology and Therapeutics·Wayne A RayKatherine T Murray
Sep 15, 2004·Journal of Toxicology. Clinical Toxicology·Geoffrey K IsbisterIan M Whyte
Jul 6, 2005·Archives of General Psychiatry·C Barr TaylorUNKNOWN ENRICHD Investigators
Jan 25, 2006·Archives of Internal Medicine·J P EmpanaD S Siscovick
Jun 21, 2006·The American Journal of Cardiology·Glen L XiongL Kristin Newby
Nov 14, 2006·Resuscitation·Tina I HorstedSøren L Nielsen
Nov 21, 2007·Journal of the American College of Cardiology·Viola VaccarinoUNKNOWN National Heart, Lung, and Blood Institute
Jan 18, 2008·The New England Journal of Medicine·Erick H TurnerRobert Rosenthal
Mar 14, 2009·Journal of the American College of Cardiology·William WhangChristine M Albert
Aug 5, 2009·Archives of General Psychiatry·Mark Olfson, Steven C Marcus

❮ Previous
Next ❯

Citations

Mar 20, 2014·European Heart Journal·Søren FanoeHenning Bundgaard
Oct 18, 2013·Expert Opinion on Drug Safety·Chi-Un PaePrakash S Masand
Mar 5, 2015·Expert Opinion on Drug Metabolism & Toxicology·Janet SultanaGianluca Trifirò
Mar 16, 2016·Journal of Analytical Toxicology·Christian R MikkelsenJørgen B Hasselstrøm
Jun 11, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexander KhalafHoward Aizenstein
Sep 22, 2016·European Journal of Human Genetics : EJHG·Sofie Lindgren ChristiansenNiels Morling
Dec 28, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·Kathrine B SondergaardFredrik Folke
Nov 22, 2013·The Annals of Pharmacotherapy·Kylee A Funk, Jolene R Bostwick
Feb 6, 2015·Therapeutic Advances in Psychopharmacology·Jimmi NielsenJørgen K Kanters
Jun 6, 2015·Circulation Research·Meiso HayashiChristine M Albert
Feb 12, 2019·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K D LyckeM Nørgaard
Mar 5, 2015·Der Nervenarzt·A AgorastosC Otte
Oct 2, 2012·American Journal of Physiology. Heart and Circulatory Physiology·C Schroeder, J Jordan
Nov 22, 2013·Epidemiology·Aksel Karl Georg JensenPer Kragh Andersen
Aug 5, 2017·Psychopharmacology·Ana Ojero-SenardJean-Louis Montastruc
Mar 5, 2013·Pharmacoepidemiology and Drug Safety·Angela S CzajaHeather D Anderson
Jul 25, 2015·Alcoholism, Clinical and Experimental Research·Shu-I WuChiao-Chicy Chen
Aug 19, 2015·Current Cardiology Reports·Peter A Shapiro
Dec 20, 2019·Therapeutic Advances in Psychopharmacology·Nicolas AnsermotChin B Eap
Sep 13, 2018·Current Vascular Pharmacology·Evangelia MaretiDimitrios G Goulis
Dec 20, 2012·Clinical Pharmacology and Therapeutics·K Jensen
Jan 8, 2013·Depression and Anxiety·Nicole Mavrides, Charles Nemeroff
Oct 20, 2017·European Journal of Clinical Pharmacology·A BiffiUNKNOWN Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)
Apr 26, 2019·European Heart Journal. Case Reports·Peter MarstrandJuliane Theilade
Jun 25, 2014·Clinical Pharmacology and Therapeutics·P WeekeC Torp-Pedersen
Jan 31, 2019·European Heart Journal·Viola VaccarinoUNKNOWN ESC Scientific Document Group Reviewers
Jan 10, 2013·Clinical Pharmacology and Therapeutics·P Weeke, C Torp-Pedersen
Oct 6, 2020·Journal of Forensic Sciences·Christian Fyhn ReussJytte Banner
May 16, 2018·JACC. Clinical Electrophysiology·Bjarke RisgaardJacob Tfelt-Hansen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.